April 9, 2012 — After witnessing a downtrend for several years, revenues in the U.S. nuclear medicine and positron emission tomography (PET) imaging systems market finally pivoted in 2010. New radiotracers and technologies are expanding the clinical scope and customer base of nuclear medicine and PET imaging. As a result, declines in retrenching areas of the market are poised to be offset by strong growth in emerging end-user market segments.
April 9, 2012 — Thoratec and the U.S. Food and Drug Adminstration (FDA) announced a recent Class 1 recall of the HeartMate II left ventricular assist device (LVAD) because detachment of the bend relief from its intended position around the proximal outflow graft may allow the graft to kink or deform, resulting in reduction of blood flow. The kink also may cause pump/graft thrombosis or perforation of the outflow graft. Additionally, the metal end of the bend relief may be sharp and cause erosion and cutting of the outflow graft.
April 9, 2012 — Healthcare supply contracting company Novation released its 2012 Diagnostic Imaging Watch report. Peer reviewed by members of Novation's Diagnostic Imaging Council, the report is an overview of the latest product technology and trends for imaging subspecialties.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 6, 2012 — Crux Biomedical announced that a recently completed pivotal trial of its Crux Vena Cava Filter (VCF) System with bi-directional retrieval was presented at the 2012 Society of Interventional Radiology (SIR) Annual Scientific Meeting, March 24-29, in San Francisco. Vena cava filters are designed to trap blood clots that can lead to potentially fatal pulmonary embolisms (PE) among patients at risk. In the study, deployment and retrieval each were achieved with a 98 percent success rate.
April 6, 2012 — St. Jude Medical Inc. announced it has appointed Population Health Research Institute (PHRI), an academic health science research institute, to analyze data from three combined registries on the Riata ST Optim and Durata implantable cardioverter defibrillator (ICD) leads. The analysis will be entirely under the control of PHRI, who will complete a review of the performance of the leads.
April 6, 2012 — The U.S. anticoagulant market is on the verge of a major shift in clinical practice, transitioning from a market dominated by a single injectable anticoagulant to a highly competitive one dominated by first-in-class novel oral anticoagulants. Companies are vying with each other to introduce novel therapies that offer superior safety, efficacy and convenience to patients and physicians.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The Crux inferior vena cava (IVC) filter was designed for easy deployment and later retrival. This video clip shows ...
Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart ...
The Crux inferior vena cava (IVC) filter was designed for easy deployment and later retrieval. This video clip shows ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Several interventional cardiology experts share their views on how fractional flow reserve (FFR) and optical coherence ...
Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart ...
Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart ...
April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the company's radiopharmaceutical manufacturing facility in Crown Point, Ind.
April 6, 2012 — AliveCor, developer of the mobile electrocardiogram (ECG) recorder, announced results from a study that demonstrated how the company’s ECG monitoring device is intuitive and allows users to learn and characterize their heart rates by using the hand-held device in their hands or on their chest. The data from the credit-card-sized wireless device is designed to help physicians and health care providers monitor and assess their patients’ heart health for a variety of medical reasons.